• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number ECH060040J
Device Problems Complete Blockage (1094); Peeled/Delaminated (1454)
Patient Problems Hematoma (1884); Obstruction/Occlusion (2422)
Event Date 07/06/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on an unknown date in (b)(6) 2017, the patient underwent a shunt construction procedure (the right radial artery to basilic vein) for dialysis utilizing a gore® acuseal vascular graft.On (b)(6) 2021, a percutaneous transluminal angioplasty (pta) was performed in response to stenosis found near an anastomosis of a vein in the gore® acuseal vascular graft.On (b)(6) 2021, an occlusion of the gore® acuseal vascular graft was observed.An echo image revealed that there was a delamination in the cannulation site near the apex of the vascular loop, slightly towards the vein.Additionally, a hematoma was observed between the layers.Reportedly, this delamination and the stenosis confirmed on (b)(6) 2021 were in different areas.On (b)(6) 2021, part of the gore® acuseal vascular graft containing the delamination was removed and a gore® viabahn® endoprosthesis with propaten bioactive surface was used as an extension.The physician stated that the delamination was confirmed in the cannulation site.He suggested that the needle might have been inserted between layers of the gore® acuseal vascular graft because the cannulation angle was shallow.
 
Manufacturer Narrative
The device was not returned, but device pictures were provided for analysis: the identity of the device was provided; no abnormalities were found in the associated device history record.The evaluation found no anomalies attributable to the manufacture of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key12293876
MDR Text Key265586154
Report Number2017233-2021-02222
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/06/2019
Device Catalogue NumberECH060040J
Was Device Available for Evaluation? No
Date Manufacturer Received07/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age68 YR
-
-